02 February 2024
BARONSMEAD SECOND VENTURE TRUST PLC
("THE COMPANY")
PCA Notification
On 31 January 2024, Ms Caroline Groat, a Person Closely Associated (PCA) with Mr Malcolm Groat, a Non-Executive Director of the Company, sold 43,032 Ordinary Shares in the Company. Following this transaction, Ms Caroline Groat, a PCA of Mr Malcolm Groat holds 263,740 Ordinary Shares in the Company.
1. | Details of PDMR / person closely associated with them (?PCA?) | |||||
a) | Name | Ms Caroline Groat | ||||
2. | Reason for the notification | |||||
b) | Position / status | PCA of Malcolm Groat, Non-Executive Director and PDMR | ||||
c) | Initial notification / amendment | Initial Notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Baronsmead Second Venture Trust plc | ||||
b) | LEI | 2138008D3WUMF6TW8C28 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument
Identification Code | Ordinary Shares of £0.10 each
ISIN: GB0030028103 | ||||
b) | Nature of the transaction | Sale of Ordinary Shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | N/A ? single transaction | ||||
e) | Date of the transaction | 31-01-2024 | ||||
f) | Place of the transaction | London Stock Exchange (XLON) |
For further information please contact:
Baronsmead VCT Investor Relations
020 7382 0999
baronsmeadvcts@greshamhouse.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.